Clinical research
Mission
At Nephrology Associates of Northern Virginia (NANV), our mission is to provide the highest quality of patient care while participating in clinical studies for the advancement of medical research related to kidney disease. The research is conducted by highly professional research staff and experienced investigators who are board certified physicians.
Vision
Nephrology Associates of Northern Virginia (NANV) works with research organizations and biopharmaceutical companies to provide opportunities to allow our patients to gain access to new investigational treatments that are not yet available to the public. Ultimately, our goal is to further the advancement of medical knowledge related to kidney disease. We are committed to providing a comfortable patient experience throughout the participation of all clinical studies.
Core Values
Promote the safety and welfare of our participants by following federal regulations, state laws, Good Clinical Practice (GCP) guidelines, Institutional Review Board (IRB) policies, and organizational policies.
Apply the principles of respect, beneficence, and justice from the Belmont Report when working with all clinical study participants.
Promote transparency in all aspects of clinical research such as informed consent, monitor visits, audits, and regular updates for sponsors, clinical research organizations, and practice partners.
History
Our research team has participated in more than 25 clinical studies since 2006 to research safe and effective medical interventions for the following health conditions:
Anemia associated with Chronic Kidney Disease (CKD) for dialysis and non-dialysis patients
End Stage Renal Disease (ESRD)
Hyperphosphatemia in ESRD patients
Diabetic Nephropathy
Type 2 Diabetes Mellitus with moderate renal impairment
Type 2 Diabetes Mellitus with persistent proteinuria
Secondary Hyperparathyroidism associated with Chronic Kidney Disease (CKD) for hemodialysis patients
What are Clinical Trials and How They Work:
Clinical research studies, also called clinical trials, look for new ways to prevent, detect, and treat diseases and illnesses. Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments.
The goal of clinical trials is to determine if a new test or treatment works and is safe. Before a new medical device or pharmaceutical drug is approved for general use, it goes through rigorous testing to ensure its safety and efficacy for use on people.
Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses.
Before a clinical trial can begin to enroll study participants, the trial must be approved and monitored by an Institutional Review Board (IRB), or Ethics Committee (EC), made up of members who review and approve research studies with the goal to protect the rights and welfare of those recruited to participate in research activities.
All personal information provided by study participants will be kept confidential and will never be linked to any person outside of the study unless required by law.